Targeted X-ray treatment of mice prevents glaucoma

March 19, 2012

Jackson Laboratory researchers have demonstrated that a single, targeted x-ray treatment of an individual eye in young, glaucoma-prone mice provided that eye with apparently life-long and typically complete protection from glaucoma.

In research published March 19 in the , Gareth Howell, Ph.D., Simon John, Ph.D., (professor and Howard Hughes Medical Investigator) and colleagues also used sophisticated genomics methods to uncover some of the very first pathways to change during glaucoma in these mice. The first pathway they detected to change suggests a critical mechanism that could be responsible for the earliest damage that glaucoma inflicts on the .

Glaucoma, a leading cause of blindness, affects more than 4 million Americans, at least half of who don't even know they have the disease. Current treatments target intraocular pressure elevation, the best-known risk factor for glaucoma. However, blindness-inducing damage to and the optic nerve can occur in patients with normal intraocular . Earlier detection and better treatments could therefore have a powerful impact on preventing blindness due to glaucoma.

About 10 years ago, the John lab made the surprising discovery that just a single dose of whole body irradiation along with bone marrow transfer conferred an unprecedented protection against glaucoma. 96% of treated eyes had no glaucoma a year later compared to only 20% of control eyes. Although this result was unexpected, there is some evidence that radiation may protect from human glaucoma. who followed Japanese survivors of the atomic bombings in had noticed that exposure to radiation increased the incidence of thyroid and other cancers but seemed to provide protection against glaucoma.

The John labs' new demonstration that irradiation of just a single eye is protective, and at lower doses than they previously published, raises the possibility of using highly controlled localized radiation of just the eye to prevent human glaucoma.

Further research in other animal models to assess protection as well as safety and efficacy is necessary before attempting human treatments. But, as the authors conclude in their paper, "given both the robust and long-term efficacy of a single dose of X-ray radiation in preventing cellular entry into the optic nerve and retina, it will be important to further evaluate the use of X-rays for preventing glaucoma."

The study showed that in response to early tissue stresses, a class of immune cells known as monocytes, enter the optic nerve and retina in glaucoma. These monocytes express damaging molecules that appear critical for nerve damage in . The entry of these cells is controlled in part by endothelial cells that line blood vessels. Radiation treatment appears to change how these endothelial cells respond to the early tissue stresses and affect the entry of the monocytes into the optic nerve and retina.

"While more work is needed to fully understand how the radiation confers long-term protection," Howell says, "radiation appears to hinder the adhesion and migration of monocytes into the areas of the eye prone to nerve damage." This finding strongly implicates the entry of cells into the eye as a key component of the that leads to blindness. It also suggests vision may be maintained in eyes with high by treatments that block the entry of monocytes into eye.

Explore further: New research characterizes glaucoma as neurologic disorder rather than eye disease

More information: Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma: www.jci.org/articles/view/6113 … 82201f32dfe421d1d337

Related Stories

New research characterizes glaucoma as neurologic disorder rather than eye disease

March 7, 2012
A new paradigm to explain glaucoma is rapidly emerging, and it is generating brain-based treatment advances that may ultimately vanquish the disease known as the "sneak thief of sight." A review now available in Ophthalmology, ...

Recommended for you

Curve-eye-ture: How to grow artificial corneas

October 19, 2017
Scientists at Newcastle University, UK, and the University of California have developed a new method to grow curved human corneas improving the quality and transparency - solely by controlling the behaviour of cells in a ...

Clinical study success for novel contact lens device aimed to improve glaucoma treatment

October 19, 2017
A novel contact lens device developed by University of Liverpool engineers to improve the treatment of glaucoma has been found to reliably track pressure changes in the eye and be wearable by people who took part in its first ...

Study indicates proof of concept for using a surrogate liquid biopsy to provide genetic profile of retinoblastoma tumors

October 12, 2017
Retinoblastoma is a tumor of the retina that generally affects children under 5 years of age. If not diagnosed early, retinoblastoma may result in loss of one or both eyes and can be fatal. Unlike most cancers that are diagnosed ...

Farsighted children struggle with attention, study finds

October 10, 2017
Farsighted preschoolers and kindergartners have a harder time paying attention and that could put them at risk of slipping behind in school, a new study suggests.

New drug reduces rate of progression of incurable eye disease

October 4, 2017
An international study including researchers from the Centre for Eye Research Australia (CERA) has found a way to slow the progression of dry age-related macular degeneration (AMD) - one of the most common causes of vision ...

Gene therapy shows promise for reversing blindness

October 2, 2017
Most causes of untreatable blindness occur due to loss of the millions of light sensitive photoreceptor cells that line the retina, similar to the pixels in a digital camera.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.